KSI kneat.com inc

Global Equipment Manufacturer Selects Kneat

Global Equipment Manufacturer Selects Kneat

LIMERICK, Ireland, Aug. 22, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a leading manufacturer of equipment systems used across diverse industries, including healthcare (“the Company”) has signed a three-year Master Services Agreement with Kneat.

The Company, headquartered in Europe, employs more than 15,000 people and markets an extensive portfolio of products in over 120 countries. Under this agreement, the Company will implement the Kneat Gx platform to digitize its equipment testing processes, enhancing delivery quality and client handover. Deployment will begin at two of its strategic European sites.

"We are delighted to welcome a top-tier equipment manufacturer as a Kneat customer,” said Eddie Ryan, CEO of Kneat. “With a shared commitment to serving the global manufacturing sector, and with its zero-code Kneat Gx platform to streamline validation and quality testing processes, Kneat is well positioned to be a long-term partner in their digital transformation journey.”

This agreement represents Kneat’s seventh strategic customer win in 2025. It follows a record-setting quarter for new customer additions, as life sciences and other industries expand their digital capabilities to drive quality, compliance, and accelerated speed to market.

About Kneat

Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. compliance standard. Independent customer studies have shown Kneat Gx to reduce labor hours associated with validation documentation by more than 50%, accelerate review and approval cycles by up to 50%, and consistently support higher standards of regulatory compliance. For more information visit .

For further information:

Katie Keita, Kneat Investor Relations

P: 0

E:  



EN
22/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on kneat.com inc

 PRESS RELEASE

Global Pharmaceutical Packaging Manufacturer Selects Kneat

Global Pharmaceutical Packaging Manufacturer Selects Kneat LIMERICK, Ireland, Feb. 19, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), the global leader in digital validation and quality process automation, today announced it has signed a Master Services Agreement with a U.S.-headquartered global pharmaceutical packaging and drug-delivery manufacturer. This new customer operates more than 45 manufacturing facilities worldwide, including over a dozen GMP-regulated sites, and employs over 13,000 people across the United States, Europe, Asia, and South America. Under th...

 PRESS RELEASE

Kneat to Announce 2025 Fourth-Quarter and Year-End Financial Results F...

Kneat to Announce 2025 Fourth-Quarter and Year-End Financial Results February 25, 2026 LIMERICK, Ireland, Feb. 04, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI, OTCQX: KSIOF) (“Kneat” or the “Company”), a leader in digitizing and automating validation and quality processes, announced today that the Company will release its financial results for the quarter ended December 31, 2025, after TSX market close on February 25, 2026. Eddie Ryan, Chief Executive Officer and Dave O’Reilly, Chief Financial Officer, will host a conference call and Q&A for sell side analysts via webcast on Febru...

 PRESS RELEASE

Global Biopharma Solutions Leader Selects Kneat to Drive Digital Valid...

Global Biopharma Solutions Leader Selects Kneat to Drive Digital Validation Excellence LIMERICK, Ireland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), the global leader in digital validation and quality process automation, today announced a Master Services Agreement with one of the world’s leading providers of biopharma research and manufacturing technologies (“the Company”). Headquartered in Europe and operating across more than 60 global locations, this 13,000+ employee organization will begin deploying Kneat’s platform for equipment validation at severa...

 PRESS RELEASE

Global Specialty Chemicals Leader Chooses Kneat for Digital Validation

Global Specialty Chemicals Leader Chooses Kneat for Digital Validation Strategic win fuels record growth in new customer additions for 2025 LIMERICK, Ireland, Dec. 17, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), the global leader in digital validation and quality process automation, has signed a three-year Master Services Agreement with one of the world’s largest makers of specialty chemicals (“the Company”). This deal adds significant momentum to what is already a record year for new customer additions at Kneat. The Company has headquarters in Europe and a foot...

 PRESS RELEASE

Kneat Announces Record Revenue for Third Quarter 2025

Kneat Announces Record Revenue for Third Quarter 2025 SaaS Revenue Growth Accelerates to 33% Year over Year LIMERICK, Ireland, Nov. 12, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, today announced financial results for the three-month period ended September 30, 2025. All dollar amounts are presented in Canadian dollars unless otherwise stated. Third-quarter 2025 total revenue reaches $16.1 million, an increase of 26% year over yearThird-quarter SaaS revenue reached $...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch